11/6
07:32 am
vrca
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Medium
Report
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
11/5
02:32 pm
vrca
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
11/5
02:21 pm
vrca
Rating for VRCA
Medium
Report
Rating for VRCA
11/5
02:21 pm
vrca
Rating for VRCA
Medium
Report
Rating for VRCA
11/5
10:48 am
vrca
Rating for VRCA
Medium
Report
Rating for VRCA
11/5
10:48 am
vrca
Rating for VRCA
Medium
Report
Rating for VRCA
11/5
07:00 am
vrca
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.
High
Report
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.
11/5
07:00 am
vrca
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.
High
Report
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.
11/5
05:11 am
vrca
Verrica downgraded to Sector Perform from Outperform at RBC Capital
High
Report
Verrica downgraded to Sector Perform from Outperform at RBC Capital
11/5
05:11 am
vrca
Verrica downgraded to Sector Perform from Outperform at RBC Capital
High
Report
Verrica downgraded to Sector Perform from Outperform at RBC Capital
10/4
11:55 am
vrca
Rating for VRCA
High
Report
Rating for VRCA
10/4
11:55 am
vrca
Rating for VRCA
High
Report
Rating for VRCA
10/3
08:18 am
vrca
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
High
Report
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
10/3
05:31 am
vrca
Rating for VRCA
High
Report
Rating for VRCA
10/3
05:31 am
vrca
Rating for VRCA
High
Report
Rating for VRCA
10/3
05:04 am
vrca
Verrica downgraded to Hold from Buy at Needham (yesterday)
High
Report
Verrica downgraded to Hold from Buy at Needham (yesterday)
10/3
05:04 am
vrca
Verrica downgraded to Hold from Buy at Needham (yesterday)
High
Report
Verrica downgraded to Hold from Buy at Needham (yesterday)